Skip to content

Artificial Intelligence-based Mortality Prediction Among Cancer Patients in the Hospice Ward

Artificial Intelligence-based Activity Recognition and Mortality Prediction Using Circadian Rhythm, Among Cancer Patients in the Hospice Ward

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04883879
Enrollment
80
Registered
2021-05-12
Start date
2019-12-11
Completion date
2021-12-31
Last updated
2021-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End Stage Cancer

Keywords

Wearable Device, Actigraphy Device, Survival Prediction, Deep Learning, Artificial Intelligence, Hospice Care, Palliative Care

Brief summary

The purpose of this study is to develop a novel deep-learning-based survival prediction model employing patient activity data recorded by a wearable device.

Detailed description

This study aims to develop a deep-learning-based survival prediction model that utilizes patient movement data upon admission to predict their clinical outcomes: either death or discharge with stable condition. Objective data of the patients are recorded by a wearable device and documented as parameters of physical activity, angle, and spin. In addition to objective data, the investigators also document patients' Karnofsky Performance Status assessed subjectively by clinical doctors. Finally, the investigators aim to explore and describe the applicability, potential, and limitations of the survival prediction model based on patient movement data as a simple prognostic parameter in clinical settings.

Interventions

None listed

Sponsors

Ministry of Science and Technology, Taiwan
CollaboratorOTHER_GOV
Taipei Medical University Hospital
CollaboratorOTHER
National Yang Ming Chiao Tung University
CollaboratorOTHER
Taipei Medical University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Participants aged 20 years or older admitted to the hospice care unit at Taipei Medical University Hospital * Participants diagnosed with at least one end-stage solid tumor diseases * Participants consented to receive hospice care

Exclusion criteria

* Participants aged below 20 years of age * Participants diagnosed with leukemia or carcinoma of unknown primary * Participants with evident signs of approaching death upon admission * Participants with no vital signs upon admission * Participants who continued to receive aggressive treatment despite admission to the hospice care unit

Design outcomes

Primary

MeasureTime frameDescription
Specificity and Sensitivity of using Artificial Intelligence based models for prediction of Clinical Outcomes of End-stage Cancer Patients using actigraphy dataFrom date of admission to hospice ward until the date of first documented discharge from hospital or date of death from any cause, whichever came first, assessed up to 1 monthThe primary outcome of the study will be to evaluate whether the analysis of the movement data captured using actigraphy device can help to predict clinical outcomes either deceased or discharged alive from hospital, with a high specificity and sensitivity, using Artificial Intelligence based prediction modelling.

Countries

Taiwan

Contacts

Primary ContactShabbir Syed-Abdul, PhD
drshabbir@tmu.edu.tw886 2-6638-2736

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026